Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta‑analysis and systematic review of 1,388 patients
- DOI
- 10.3892/ol.2026.15843
- Published
- 2026-09-02
- Container
- Oncology Letters
- Publisher
- Spandidos Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3892/ol.2026.15843,
title = {Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta‑analysis and systematic review of 1,388 patients},
author = {Lichaoyue Sun and Wenshu Li and Wei Chen and Chunxing Li and Zhao Ren and Qing Xie and Dongxiao Wang},
year = {2026},
journal = {Oncology Letters},
doi = {10.3892/ol.2026.15843},
url = {https://doi.org/10.3892/ol.2026.15843}
}RIS
TY - JOUR TI - Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta‑analysis and systematic review of 1,388 patients AU - Lichaoyue Sun AU - Wenshu Li AU - Wei Chen AU - Chunxing Li AU - Zhao Ren AU - Qing Xie AU - Dongxiao Wang PY - 2026 JO - Oncology Letters DO - 10.3892/ol.2026.15843 UR - https://doi.org/10.3892/ol.2026.15843 ER -
APA
Sun, L., Li, W., Chen, W., Li, C., Ren, Z., Xie, Q., & Wang, D. (2026). Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta‑analysis and systematic review of 1,388 patients. Oncology Letters. https://doi.org/10.3892/ol.2026.15843
Source records
- crossref · retrieved 2026-09-26T09:36:45.649Z